Powder: -20°C for 3 years | In solvent: -80°C for 1 year
NCB-0846 is an orally active TNIK inhibitor (IC50: 21 nM).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 31.00 | |
5 mg | In stock | $ 72.00 | |
10 mg | In stock | $ 122.00 | |
25 mg | In stock | $ 263.00 | |
50 mg | In stock | $ 447.00 | |
100 mg | In stock | $ 659.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 79.00 |
Description | NCB-0846 is an orally active TNIK inhibitor (IC50: 21 nM). |
Targets&IC50 | TNIK:21 nM |
In vivo | Sixty normal male and female volunteers between 18 and 40 years of age were recruited for a double-masked, placebo-controlled, crossover study in which each eye of each subject was dilated with 2.5% phenylephrine. After one hour, one eye was treated with 0.5% dapiprazole, and the contralateral eye was treated with placebo. |
Synonyms | NCB 0846 |
Molecular Weight | 375.42 |
Formula | C21H21N5O2 |
CAS No. | 1792999-26-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 30 mg/mL
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
NCB-0846 1792999-26-8 Cytoskeletal Signaling MAPK Stem Cells Wnt/beta-catenin Wnt MAPK Kinase Kinase Kinase Inhibitor inhibit NCB 0846 MAP4K NCB0846 inhibitor